Northwest Investment Counselors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.35K | Buy |
+17
| New | +$3.35K | ﹤0.01% | 526 |
|
|
2024
Q2 | – | Sell |
-17
| Closed | -$4.61K | – | 213 |
|
|
2024
Q1 | $4.61K | Buy |
+17
| New | +$4.61K | ﹤0.01% | 440 |
|
|
2023
Q4 | – | Sell |
-17
| Closed | -$3.33K | – | 212 |
|
|
2023
Q3 | $3.33K | Hold |
17
| – | – | ﹤0.01% | 484 |
|
|
2023
Q2 | $3.57K | Hold |
17
| – | – | ﹤0.01% | 482 |
|
|
2023
Q1 | $3.43K | Hold |
17
| – | – | ﹤0.01% | 484 |
|
|
2022
Q4 | $3.7K | Hold |
17
| – | – | ﹤0.01% | 490 |
|
|
2022
Q3 | $3K | Hold |
17
| – | – | ﹤0.01% | 467 |
|
|
2022
Q2 | $4K | Hold |
17
| – | – | ﹤0.01% | 449 |
|
|
2022
Q1 | $5K | Hold |
17
| – | – | ﹤0.01% | 460 |
|
|
2021
Q4 | $6K | Buy |
+17
| New | +$6K | ﹤0.01% | 424 |
|
|
2021
Q2 | – | Sell |
-17
| Closed | -$5K | – | 200 |
|
|
2021
Q1 | $5K | Buy |
+17
| New | +$5K | ﹤0.01% | 430 |
|
|
2020
Q4 | – | Sell |
-17
| Closed | -$4K | – | 198 |
|
|
2020
Q3 | $4K | Buy |
+17
| New | +$4K | ﹤0.01% | 410 |
|
|
2019
Q4 | – | Sell |
-17
| Closed | -$2K | – | 217 |
|
|
2019
Q3 | $2K | Buy |
+17
| New | +$2K | ﹤0.01% | 502 |
|